Dr. Rhee, one of the world’s leading authorities in glaucoma, comes to us following an extensive national search. Since 2005 he has served in multiple roles at the Massachusetts Eye and Ear Infirmary and Harvard Medical School, most recently as associate professor, associate surgeon, and medical director of strategic network development.
Dr. Rhee specializes in complex and high-risk cases of glaucoma, the second-leading cause of blindness, with an interest in rare clinical syndromes. His scientific research is focused on finding a cure for glaucoma by determining its cellular and molecular causes while developing directed gene therapy as a viable treatment.
His clinical research interests include evaluating the outcomes of both traditional and advanced surgical procedures to develop new therapies. Throughout his career, Dr. Rhee has developed innovative strategies, techniques, and devices for both glaucoma and cataract surgery.
Dr. Rhee has held numerous leadership roles in the Massachusetts Eye and Ear Infirmary, Harvard Ophthalmology Department and professional organizations. He currently serves as vice president of the Massachusetts Society of Eye Physicians and Surgeons and president of the Korean American Ophthalmologic Society.
He has received the American Glaucoma Society’s Clinician-Scientist Award twice and, in 2008, was honored with the Mid-Career Physician-Scientist Award. He was also awarded the RPB Physician-Scientist Award from the Research to Prevent Blindness organization.
Dr. Rhee earned his medical degree at the University of Michigan Medical School and completed his ophthalmology residency at Wills Eye Hospital in Philadelphia. He completed a clinical glaucoma fellowship at Bascom Palmer Eye Institute in Miami and a post-doctoral laboratory fellowship at the National Eye Institute of the National Institutes of Health in Bethesda, Md.
Please join us in congratulating Dr. Rhee on his appointment and welcoming him to UH Case Medical Center and Case Western Reserve University School of Medicine.